Data on the anti-cancer activity of Histogen's multipotent compositions has been
published in the July 2013 Journal of Cancer Therapy, showing reduction in multiple skin cancer cell lines in vitro.
- Histogen Aesthetics Acquires CellCeuticals Biomedical Skin Treatments
- Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally
- Multipotent Stem Cell Proteins Support Soft Tissue Regeneration
- Multipotent Stem Cell Proteins Support Rejuvenation while Inhibiting Skin Cancer
© Histogen Inc., CA 92121